These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29757629)

  • 1. Signature of Antibody Domain Exchange by Native Mass Spectrometry and Collision-Induced Unfolding.
    Watanabe Y; Vasiljevic S; Allen JD; Seabright GE; Duyvesteyn HME; Doores KJ; Crispin M; Struwe WB
    Anal Chem; 2018 Jun; 90(12):7325-7331. PubMed ID: 29757629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
    Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
    J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
    Doores KJ; Huber M; Le KM; Wang SK; Doyle-Cooper C; Cooper A; Pantophlet R; Wong CH; Nemazee D; Burton DR
    J Virol; 2013 Feb; 87(4):2234-41. PubMed ID: 23221565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12.
    Wu Y; West AP; Kim HJ; Thornton ME; Ward AB; Bjorkman PJ
    Cell Rep; 2013 Dec; 5(5):1443-55. PubMed ID: 24316082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very few substitutions in a germ line antibody are required to initiate significant domain exchange.
    Huber M; Le KM; Doores KJ; Fulton Z; Stanfield RL; Wilson IA; Burton DR
    J Virol; 2010 Oct; 84(20):10700-7. PubMed ID: 20702640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A strategy for phage display selection of functional domain-exchanged immunoglobulin scaffolds with high affinity for glycan targets.
    Stewart A; Liu Y; Lai JR
    J Immunol Methods; 2012 Feb; 376(1-2):150-5. PubMed ID: 22233878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Middle Level IM-MS and CIU Experiments for Improved Therapeutic Immunoglobulin Subclass Fingerprinting.
    Botzanowski T; Hernandez-Alba O; Malissard M; Wagner-Rousset E; Deslignière E; Colas O; Haeuw JF; Beck A; Cianférani S
    Anal Chem; 2020 Jul; 92(13):8827-8835. PubMed ID: 32453570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native Mass Spectrometry, Ion Mobility, and Collision-Induced Unfolding for Conformational Characterization of IgG4 Monoclonal Antibodies.
    Hernandez-Alba O; Wagner-Rousset E; Beck A; Cianférani S
    Anal Chem; 2018 Aug; 90(15):8865-8872. PubMed ID: 29956914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1.
    Gach JS; Furtmüller PG; Quendler H; Messner P; Wagner R; Katinger H; Kunert R
    J Biol Chem; 2010 Jan; 285(2):1122-7. PubMed ID: 19903812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody.
    Zhang MY; Xiao X; Sidorov IA; Choudhry V; Cham F; Zhang PF; Bouma P; Zwick M; Choudhary A; Montefiori DC; Broder CC; Burton DR; Quinnan GV; Dimitrov DS
    J Virol; 2004 Sep; 78(17):9233-42. PubMed ID: 15308718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
    Ionescu RM; Vlasak J; Price C; Kirchmeier M
    J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.
    Yang Q; Li C; Wei Y; Huang W; Wang LX
    Bioconjug Chem; 2010 May; 21(5):875-83. PubMed ID: 20369886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies.
    Sanders RW; Derking R; Cupo A; Julien JP; Yasmeen A; de Val N; Kim HJ; Blattner C; de la Peña AT; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; van Gils MJ; King CR; Wilson IA; Ward AB; Klasse PJ; Moore JP
    PLoS Pathog; 2013 Sep; 9(9):e1003618. PubMed ID: 24068931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy.
    Murin CD; Julien JP; Sok D; Stanfield RL; Khayat R; Cupo A; Moore JP; Burton DR; Wilson IA; Ward AB
    J Virol; 2014 Sep; 88(17):10177-88. PubMed ID: 24965454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation.
    Debaene F; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2013 Oct; 85(20):9785-92. PubMed ID: 24007193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfolding and aggregation of a glycosylated monoclonal antibody on a cation exchange column. Part II. Protein structure effects by hydrogen deuterium exchange mass spectrometry.
    Guo J; Carta G
    J Chromatogr A; 2014 Aug; 1356():129-37. PubMed ID: 25011681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dimeric form of the HIV-1 antibody 2G12 elicits potent antibody-dependent cellular cytotoxicity.
    Klein JS; Webster A; Gnanapragasam PN; Galimidi RP; Bjorkman PJ
    AIDS; 2010 Jul; 24(11):1633-40. PubMed ID: 20597163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electron microscopic and immunochemical analysis of the broadly neutralizing HIV-1-specific, anti-carbohydrate antibody, 2G12.
    Roux KH; Zhu P; Seavy M; Katinger H; Kunert R; Seamon V
    Mol Immunol; 2004 Aug; 41(10):1001-11. PubMed ID: 15302162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.